Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.01 USD | -2.88% | -2.88% | -7.34% |
May. 09 | Transcript : Lineage Cell Therapeutics, Inc., Q1 2024 Earnings Call, May 09, 2024 | |
May. 09 | Earnings Flash (LCTX) LINEAGE CELL THERAPEUTICS Reports Q1 Revenue $1.4M, vs. Street Est of $1.36M | MT |
Financials (USD)
Sales 2024 * | 12.22M | Sales 2025 * | 5.87M | Capitalization | 191M |
---|---|---|---|---|---|
Net income 2024 * | -24M | Net income 2025 * | -35M | EV / Sales 2024 * | 15.6 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 32.5 x |
P/E ratio 2024 * |
-7.77
x | P/E ratio 2025 * |
-5.87
x | Employees | 72 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.57% |
Latest transcript on Lineage Cell Therapeutics, Inc.
1 day | -2.88% | ||
1 week | -2.88% | ||
Current month | -7.34% | ||
1 month | -12.17% | ||
3 months | -4.72% | ||
6 months | +5.20% | ||
Current year | -7.34% |
Managers | Title | Age | Since |
---|---|---|---|
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Jill Howe
DFI | Director of Finance/CFO | 48 | 22-11-13 |
Chief Operating Officer | - | 09-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Neal Bradsher
BRD | Director/Board Member | 58 | 09-06-30 |
Brian Culley
CEO | Chief Executive Officer | 53 | 18-09-16 |
Deborah Andrews
BRD | Director/Board Member | 66 | 14-04-10 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - | |
0.00% | 34 M€ | +4.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 1.01 | -2.88% | 1,320,137 |
24-05-20 | 1.04 | -3.70% | 953,573 |
24-05-17 | 1.08 | +1.89% | 1,361,186 |
24-05-16 | 1.06 | -2.75% | 736,246 |
24-05-15 | 1.09 | +4.81% | 979,899 |
Delayed Quote Nyse, May 21, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-7.34% | 191M | |
+44.48% | 55.07B | |
+43.12% | 40.22B | |
-0.86% | 41.79B | |
-7.59% | 28.17B | |
+12.30% | 26.28B | |
-21.83% | 18.93B | |
+7.15% | 13.03B | |
+29.40% | 12.26B | |
+25.15% | 12.21B |
- Stock Market
- Equities
- LCTX Stock